Fundraising Fox
/People
Sign in

Marie Sockeel

Chief Medical Officer, MD at Primaa

France

Find your path to Marie

224 people in our graph can introduce you to Marie.

Sign up to see every warm intro you have to Marie

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Marie. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Marie Sockeel is a pathologist who co-founded Primaa in 2018 with Fanny Sockeel Massard and Stéphane Sockeel, and serves as its Chief Medical Officer, leading medical and clinical strategy including clinical validation of AI algorithms and regulatory work under EU IVDR 2017/746. She led the BreastPerf2023 clinical study, which supported the CE IVDR marking of Primaa's Cleo Breast solution. Since 2025, she has been a board member of France Biotech.

Experience

  1. France BiotechBoard Membercurrent2025 — present
  2. PrimaaCo-Founder and Chief Medical Officercurrent2018 — presentParis, Île-de-France, France
  3. AP-HP, Assistance Publique - Hôpitaux de ParisMD Pathologist (Praticien Hospitalier) @ Hôpital Saint-Louis, APHP, Paris2019 — 2021Paris
  4. PRAXEA DiagnosticsMD Pathologist2016 — 2018Greater Paris Metropolitan Region
  5. AP-HP, Assistance Publique - Hôpitaux de ParisFellow, hôpitaux de Bichat, Saint Louis et Lariboisière / APHP / Paris2014 — 2017Greater Paris Metropolitan Region

Frequently asked questions

Who is Marie Sockeel?
Marie Sockeel is a pathologist who co-founded Primaa in 2018 with Fanny Sockeel Massard and Stéphane Sockeel, and serves as its Chief Medical Officer, leading medical and clinical strategy including clinical validation of AI algorithms and regulatory work under EU IVDR 2017/746. She led the BreastPerf2023 clinical study, which supported the CE IVDR marking of Primaa's Cleo Breast solution. Since 2025, she has been a board member of France Biotech.
Where did Marie Sockeel go to school?
Marie Sockeel studied at Sciences Po (Executive Master, Gestion et Politiques de santé); Université de Picardie Jules Verne (Amiens) (Docteur en médecine, Spécialité Anatomie et Cytologie Pathologiques); Université Paris-Est Créteil (DU, Dermatopathologie).

Founder mafias

Same school

Shared employers